OXY vs SYRE · rev $13.29B vs $7.60B cap
OXY (OXY) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
OXY (OXY) common stock.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported OXY revenue for 2026-06-30 was $13.29B. Net income was $6.36B. OXY currently screens at market cap $0.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
OXY currently screens at market cap $0. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the OXY and SYRE stock pages for the full models.
Not investment advice.